Gamze Küçükosman
Zonguldak, 67600, Turkey (Türkiye)
NCT Number: NCT05499754
Direct laryngoscopy and tracheal intubation are associated with increases in intraocular pressure (IOP), intracranial pressure (ICP), heart rate (HR), and blood pressure. The use of supraglottic airway devices (SADs) are known to be beneficial in overcoming the disadvantages of laryngoscopy and tracheal intubation, especially ocular and pressure stress responses. In recent years, it has been reported that ultrasonographic measurement of optic nerve sheath diameter (ONSD) can be used in the diagnosis of increased ICP. The aim of our study is to compare the effects of Proseal laryngeal mask airway (pLMA), Suprem laryngeal mask airway (sLMA) and I-gel on hemodynamic response and ONSD during insertion in adult patients.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Zonguldak, 67600, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-, diabetic retinopathy,
a SAD was inserted by all anaesthetists participating in the study had at least 3 years experience of airway management and were experienced with both the pLMA, sLMA and I-jel. Inadequate ventilation after two attempts was considered a failed placement, and these patients were excluded, while the practitioner was freed to use an alternative airway device.
Time frame: 10 min after using supraglottic airway devices
effects of different types of laryngeal masks onoptic nerve sheath diameter
Zonguldak Bulent Ecevit University
Other
The Effect of Supralottic Airway Devicess on Hemodynamic Response and Optic Nerve Sheath Diameter. PROSEAL LMA, SUPREMA LMA, I-JEL LMA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06209034
Brain Diseases, Central Nervous System Diseases
Kocaeli, Turkey (Türkiye)
View Trial DetailsNCT03707054
Abdominal Compartment Syndrome, Brain Diseases
Weston, Florida, United States
View Trial DetailsNCT06428461
Arm Injuries, Brain Diseases
Denizli, Pamukkale, Turkey (Türkiye)
View Trial DetailsNCT07407972
Brain Diseases, Central Nervous System Diseases
Bursa, Turkey (Türkiye)
View Trial Details